Caesarea, Israel

Enopace Biomedical Ltd.

Calculating rank
USPTO Granted Patents = 10

% Expired Patents = 10.0


Forward Citations = 186

Loading Chart...
Loading Chart...

17 inventors (with patents filed for the assignee):

goldMedal Amir Dagan (9 out of 11 patents)

silverMedal Gal Ariav (8 out of 10 patents)

bronzeMedal Nitai Hanani (6 out of 9 patents)

4.  Yossi Gross (5 out of 266 patents)

5.  Offer Glasberg (5 out of 12 patents)

6.  Yotam Reisner (4 out of 6 patents)

7.  Tanhum Feld (2 out of 56 patents)

8.  Oded Meiri (2 out of 57 patents)

9.  Igor Gindin (2 out of 2 patents)

10.  Yoav Katz (2 out of 4 patents)

11.  Fabian Lipperman (2 out of 2 patents)

12.  Nadav Peleg (2 out of 2 patents)

13.  Moshe Elazar (1 out of 2 patents)

14.  Vadim Bernshtein (1 out of 1 patent)

15.  Nir Armony (1 out of 1 patent)


10 patents:

Company Overview
Enopace Biomedical Ltd. is a medical technology company based in Caesarea, Israel, specializing in innovative solutions for heart failure management. The company focuses on the development of advanced medical devices that aim to improve patient outcomes through enhanced cardiac function. Enopace's research emphasizes the integration of cutting-edge technologies to create effective therapies, positioning it as a key player in the evolving landscape of cardiovascular care.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

10 Patents

#25 in Caesarea

#640 in Israel

#56,169 in the World

Caesarea, IL
Caesarea, Israel
Forward Citations = 186

17 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Enopace Biomedical Ltd.. Retrieved from https://idiyas.com/company/enopace-biomedical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…